Flagship Research Quarterly of the Indian School of Business (ISB). Find out more

Sign up  |  Log in

Anand Nandkumar

Anand-Nandakumar
Associate Professor of Strategy, at the Indian School of Business (ISB)

Clusterpreneurship: Do entrepreneurs create and sustain clusters?

The emergence of start-up activity in the ICT sector has shown an exponential increase after 2010. The trends that stand out explain the emergence of ICT start-ups and the regional concentration of start-ups in this sector. In this article, the authors trace the evolution of ICT start-ups and provide some insights on the sectoral and geographical patterns in the industry, …

Read More »

Swimming in cold waters: How MNFs protect IPR in weak IP regimes

Multinational firms (MNFs) use a variety of project selection and organisational mechanisms to make up for weak intellectual property rights (IPR) regimes in countries such as India and China, to which they offshore research and development (R&D) activities. Professor Nandkumar’s research reveals that these mechanisms enable MNFs to prevent both patentable and unpatentable knowledge from leaking out to rivals, thereby …

Read More »

Technological Innovation in India: Negotiating the Patent Ecosystem

The authors look at India’s progress in technological innovation by analysing patent data, and find that in India, unlike China, foreign entities outstrip domestic players in patents granted. The authors argue that in order for India and other emerging economies to compete effectively in the global patent landscape and become powerful knowledge economies, they must reassess their policies, institutions and …

Read More »

Entrepreneurial Firms: Coast On or Cash Out?

Environment impacts performance capabilities of entrepreneurial firms. BASED ON THE RESEARCH OF ANAND NANDKUMAR (ISB) AND ASHISH ARORA (DUKE UNIVERSITY) The typical entrepreneur dreams of creating a business that creates wealth; however, he can only do so if he survives to see his idea blossom. Further, the more accomplished he is, the more likely he would like his idea to blossom fast, …

Read More »

Novartis in India: Innovation versus Affordability

Professor Anand Nandkumar of ISB, Professor Charles Dhanaraj of Kelley School of Business, along with Mridula Anand, trace Novartis’ prolonged tussle with the Indian patent regime to get its cancer drug, Glivec, patented in India. The case is set against the backdrop of the Intellectual Property Appellate Board declining Novartis’ patent application on the grounds that the cost of the …

Read More »

Oral Insulin: Breakthrough Innovation at Biocon

The quest to be recognised as a global leader in innovation led Biocon to discover and develop IN-105, oral insulin for diabetics. Faced with initial success, the Biocon team was rearing to charge ahead with the final testing. Everything looked rosy, but was it actually so? Nita Sachan, Senior Researcher, Biocon Cell for Innovation Management at the Centre for Leadership, …

Read More »

Was the Trip Worthwhile?

This article examines the impact of the trade-related aspects of intellectual property rights (Trips) agreement on innovation in India. In 1994, India signed the Trips agreement mandated by the World Trade Organisation (WTO). The agreement, which came into effect on January 1, 1995, is the most important multilateral agreement on intellectual property (IP). By enforcing a minimum standard of IP rights …

Read More »
Scroll To Top